ProtoKinetix, Inc. (PKTX): Operating Cash Flow
-$135.4K
Year ended 2025-12-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$135.4K | n/m | 2026-09-03, From 2025-01-01 |
| 2024-12-31 | -$223.1K | n/m | 2026-09-03, From 2024-01-01 |
| 2023-12-31 | -$376.0K | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$804.7K | n/m | 2024-03-20, From 2022-01-01 |
| 2021-12-31 | -$889.9K | n/m | 2023-03-17, From 2021-01-01 |
| 2020-12-31 | -$881.3K | n/m | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | -$850.7K | n/m | 2021-03-05, From 2019-01-01 |
| 2018-12-31 | -$453.5K | n/m | 2020-02-19, From 2018-01-01 |
| 2017-12-31 | -$605.1K | n/m | 2019-03-12, From 2017-01-01 |
| 2016-12-31 | -$820.3K | n/m | 2018-03-09, From 2016-01-01 |
| 2015-12-31 | -$574.2K | n/m | 2017-02-21, From 2015-01-01 |
| 2014-12-31 | -$229.2K | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$105.3K | n/m | 2015-04-14, From 2013-01-01 |
| 2012-12-31 | -$149.9K | n/m | 2014-05-27, From 2012-01-01 |
| 2011-12-31 | -$396.6K | n/m | 2014-04-30, From 2011-01-01 |
| 2010-12-31 | -$114.9K | n/a | 2012-03-20, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| ProtoKinetix, Inc. (PKTX) | 2025-12-31 | -$135.4K | n/m |
| Bio Essence Corp (BIOE) | 2025-12-31 | $1.57M | +151.6% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | -$396.0K | n/m |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$289.8K | n/m |
| Bioxytran, Inc (BIXT) | 2025-12-31 | -$526.5K | n/m |
| ZyVersa Therapeutics, Inc. (ZVSA) | 2025-12-31 | -$5.11M | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$3.33M | n/m |
| Cell Source, Inc. (CLCS) | 2024-12-31 | -$2.68M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$383.6K | n/m |
Compare PKTX, BIOE, PMHS, BSPK side by side · Screen every company in Pharmaceutical Preparations ↗